These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15035894)

  • 1. Integrative tumor board: recurrent breast cancer or new primary? UCSF Osher Center for Integrative Medicine and UCSF Carol Franc Buck Breast Care Center.
    Jacobs BP; Burns B; Marya R; Chapman J; Stone B; Hwang S; Goldman M; Barrows K; Hamolsky D; Sampel K
    Integr Cancer Ther; 2003 Sep; 2(3):289-300. PubMed ID: 15035894
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrative tumor board: recurrent breast cancer or new primary? Naturopathic medicine.
    Fulop JA
    Integr Cancer Ther; 2003 Sep; 2(3):276-83. PubMed ID: 15035892
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology.
    Boyd DB
    Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
    Schmaltz J
    Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
    Hirsch A
    Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrative tumor board: recurrent breast cancer or new primary? Integrative physician's perspective.
    Block KI
    Integr Cancer Ther; 2003 Sep; 2(3):301-5. PubMed ID: 15035895
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrative tumor board: recurrent breast cancer or new primary? Mind-body-spirit medicine.
    Mehl-Madrona L
    Integr Cancer Ther; 2003 Sep; 2(3):283-9. PubMed ID: 15035893
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up care of patients with breast cancer.
    Tolaney SM; Winer EP
    Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [After care of breast carcinoma patients--recommendations from the Berlin consensus conference].
    Hellriegel KP; Schulz KD
    Fortschr Med; 1996 Feb; 114(5):43-5. PubMed ID: 8867474
    [No Abstract]   [Full Text] [Related]  

  • 10. Classifying "recurrent" breast cancer: lost heterozygosity found.
    Hameed O; Pfeifer JD
    Am J Clin Pathol; 2005 May; 123(5):641-3. PubMed ID: 15981802
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer.
    Ono M; Watanabe T; Shimizu C; Hiramoto N; Goto Y; Yonemori K; Kouno T; Ando M; Tamura K; Katsumata N; Fujiwara Y
    Jpn J Clin Oncol; 2008 Aug; 38(8):567-70. PubMed ID: 18617535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postexcisional recurrence of carcinoma of the breast.
    Zavotsky J; Gardner B
    J Am Coll Surg; 1996 Jan; 182(1):71-7. PubMed ID: 8542095
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.
    Bollet MA; Servant N; Neuvial P; Decraene C; Lebigot I; Meyniel JP; De Rycke Y; Savignoni A; Rigaill G; Hupé P; Fourquet A; Sigal-Zafrani B; Barillot E; Thiery JP
    J Natl Cancer Inst; 2008 Jan; 100(1):48-58. PubMed ID: 18159071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessing tumor markers in local recurrences of breast cancer: a new insight.
    Pedrini JL; Pedrini M; Savaris RF; Machado L; Grudzinski M; Zettler CG
    Med Sci Monit; 2004 Dec; 10(12):BR462-7. PubMed ID: 15567977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiosarcoma arising in recurrent phyllodes tumour.
    Mamoon N; Mushtaq S; Hassan U; Rashid R; Khadim MT; Sarfraz T; Waqar MA
    Histopathology; 2009 Jun; 54(7):913-6. PubMed ID: 19635109
    [No Abstract]   [Full Text] [Related]  

  • 19. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.
    Taylor ME; Haffty BG; Rabinovitch R; Arthur DW; Halberg FE; Strom EA; White JR; Cobleigh MA; Edge SB
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):997-1002. PubMed ID: 19251087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.